The study will scan the brains of about 180 people as they make food and money choices, looking for changes in how the reward system handles instant gratification.
Recap by typeshit. Full story at News Channel 5 Nashville.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The work looks at whether these drugs change impulsive money decisions, not just appetite. No results have been shared yet.
10:40
A clinic channel's short take on what tirzepatide does inside the body. No description came with it, so expect a general overview rather than new findings.
Loading…